Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To perform literature and patent searches
— Life science entrepreneur, USA
To monitor patent expirations/loss of exclusivity
— Pharmacy director, USA
To get information on international drug patents
— Patent agent, USA
To proactively manage the hospital's pharmaceutical inventory
— Hospital pharmacist, USA
Want to know data of final approval and tentative approval of drugs launched in the US market
— Pharmaceutical executive, USA
Generated: May 22, 2017
| Patents: | 1 |
| Tradenames: | 13 |
| Ingredients: | 13 |
| NDAs: | 15 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma Inc | DOFETILIDE | dofetilide | CAPSULE;ORAL | 207058-002 | Jun 6, 2016 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mayne Pharma Inc | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | aspirin; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 203335-001 | Oct 30, 2015 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mayne Pharma Inc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 091313-004 | Apr 29, 2016 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mayne Pharma Inc | HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 205658-001 | Nov 17, 2015 | AA | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mayne Pharma Inc | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 090177-003 | Oct 20, 2008 | AA | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
For patent related information to plan launch of generics worldwide
— Director, international business, India
Updates on patents, new and expired; market watch on IP activities
— Formulation development scientist, India
To conduct research on drug patent expirations
— Data management / business information, specialty pharmaceuticals, China
For information about patents on drugs of interest
— Information consultant, Mexico
To know the expiration dates of patents
— Regulatory affairs services, Brazil
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,314 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
